Not all growth stocks worth buying these days focus on the artificial intelligence field. There are many exciting ones in ...

After facing redundancy at the end of last year, Currie resident and single mum Lynsey Pirie has turned a daunting challenge ...

Cumberland Pharmaceuticals Inc.’s CPIX share price has dipped by 16.29%, which has investors questioning if this is right time to buy.

Limb-girdle muscular dystrophy type 2D (LGMD2D/R3) is a rare genetic disorder caused by mutations in the SGCA gene, leading to defective folding and the loss of functional α-sarcoglycan, with ...

Blizzard Entertainment and World of Warcraft players raised over $2 million for CureDuchenne, honoring Mats Steen, a devoted player lost to Duchenne muscular dystrophy, while promoting awareness and ...

Patient advocate Austin Leclaire, who died Feb. 1, played a pivotal role in spurring the development of the first medicines ...

The Elevate-44-201 study is a global, two-part, randomized, double-blind placebo-controlled phase 1/2 study evaluating the ...

Caregivers of people with Duchenne muscular dystrophy may play an important role in the prevention and management of fat ...

Barbara Goodfriend, 83, opted for medical aid in dying after being diagnosed with ALS. The New Jersey widow ended her life in ...

But the thing that's made a huge difference is having Snoopy." READ MORE: Jools Holland signs copies of new book for Muscular ...

Leah Messer tells PEOPLE about navigating high school and independence with teens Aliannah and Aleeah, 15, while also raising daughter Adalynn, 11.

has granted Fast Track designation for DYNE-101 for the treatment of myotonic dystrophy type 1 (DM1). DYNE-101 is currently being evaluated in the ongoing Phase 1/2 ACHIEVE global clinical trial.